Navigation Links
New data showed Actos prevented progression of atherosclerotic plaque volume in patients
Date:3/31/2008

Chicago, IL, March 31, 2008 New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS® (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline. These data stem from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) trial.

The PERISCOPE trial was presented today as a late breaker at the 57th Annual Scientific Session of the American College of Cardiology in Chicago. This trial adds to the body of cardiovascular data for ACTOS. ACTOS studies, conducted over the past 10 years in more than 16,000 patients, including short- and long-term trials, as well as prospective and observational studies, have shown no evidence that ACTOS is associated with an increased risk of heart attack, stroke, or death.

We are pleased with the results of the PERISCOPE, which further expands our cardiovascular data with ACTOS, said David P. Recker, M.D., senior vice president, Clinical Sciences and interim president at Takeda Global Research & Development. While not definitive, data from PERISCOPE combined with results from a previous study, looking at surrogate endpoints, have shown a consistent trend toward decreasing cardiovascular risk by reducing the atherosclerotic burden in people with type 2 diabetes.

PERISCOPE is the first clinical trial to examine the effects of an oral antidiabetic medication on the development of coronary atherosclerosis in patients with type 2 diabetes using IVUS technology. The trial conducted in 97 centers in the U.S., Canada and Latin America with 543 patients, used IVUS imaging of the coronary arteries. The analysis demonstrated a statistically significant difference in percent change in coronary artery atheroma volume in favor of ACTOS treatment compared to glimepiride t
'/>"/>

Contact: Amy Losak
amy.losak@ketchum.com
917-865-6688
Takeda Pharmaceuticals North America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
2. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
3. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
4. New study of Concerta showed significant improvement of ADHD symptom management in adults
5. African Americans at Risk for Low Calcium Intake - New Survey Finds Those Experiencing Symptoms of Lactose Intolerance May be Sidelining Dairy in Their Diets
6. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
7. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
8. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
9. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
10. One-third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
11. One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Bill Howe Plumbing, ... in San Diego. Bill Howe offers all employees ample opportunity for education and ... most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San Diego ...
(Date:6/30/2015)... ... , ... Some may define success as the sum of small efforts repeated ... Athletic Trainers’ Association (NYSATA) and its members continue to be acknowledged and applauded by ... number of members also received honors at the national level. , For ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Psychiatric ... at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will offer ... premiere event for psychiatric-mental health nursing draws more than 1,500 health care professionals ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, the leader in the ... health records system from the company exclusively dedicated to helping eye care professionals ... intuitive state-of-the-art solution combining modern cloud technology with Medflow’s proven expertise in the ...
(Date:6/30/2015)... ... ... Purdy, the spokesperson for Dephinitive Systems LLC, announces today that the company will officially ... eXtra Operability (XO) which was chosen to reflect the company’s commitment to health care ... XO, based in Cleveland OH, is part of the Cadrillion Capital family of Healthcare ...
Breaking Medicine News(10 mins):Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:Dephinitive Systems Is Getting a New Name 2
... Still Feel Targeted By Tobacco Advertising and Find It,Easy ... across Kansas will,rally against tobacco on April 2 as ... annual Kick Butts Day, sponsored by the Campaign,for Tobacco-Free ... a list of local events, go to http://www.kickbuttsday.org/events ...
... Still Feel Targeted By Tobacco Advertising & Find It,Easy ... across Florida,will rally against tobacco on April 2 as ... annual Kick Butts Day, sponsored by the,Campaign for Tobacco-Free ... a list of local events, go to, http://www.kickbuttsday.org/events )., ...
... 27 Marshall Erdman &,Associates (Erdman) was ... Healthcare,s" 2008 Construction & Design Survey. The ... industry; it,examines year-over-year sales, contracted square footage ... and number of architects, engineers,and interior designers., ...
... knowledge and building important international relationships is top ... DendriMed Research Director Dr Raisa Monteiro, when she ... in May. , One of two Australian life ... candidates for the prestigious 2008 Advancing BioBusiness Award, ...
... alliances that,lead to increased sales and are mutually ... selection of compatible partners. Companies,that succeed in alliance ... articulating the rationale behind the effort, and then,choosing ... Practices, LLC,s white paper "Generating Value From Strategic,Alliances ...
... Practice Information Management Software Introduces Comprehensive Patient and Information Tracking ... ... Back-Up, DALLAS, March 27 Eklin Medical Systems, a ... Practice Management software for veterinary care,(VIA(R)), is showcasing VIA,s new Hospital ...
Cached Medicine News:Health News:Kansas Kids 'Kick Butts' on April 2 2Health News:Kansas Kids 'Kick Butts' on April 2 3Health News:Florida Kids 'Kick Butts' on April 2 2Health News:Florida Kids 'Kick Butts' on April 2 3Health News:Florida Kids 'Kick Butts' on April 2 4Health News:'Modern Healthcare' Names Marshall Erdman Nation's Top Design-Build Company 2Health News:DendriMed scientist seeks to fast-track success 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3
(Date:6/30/2015)... , June 30, 2015  Today, the National Mobility ... the 2015 National Mobility Awareness Month Local Heroes Contest ... Hero online entries that received 1.3 million votes. The ... , Toyota Mobility , and Valley Honda ... and Vantage Mobility International (VMI) and ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... BROOMFIELD, Colo., April 12, 2011 Lanx ® , ... developing and commercializing innovative devices for spinal surgery, today ... (Concero) at the 2011 American Association of Neurological Surgeons ... Concero system is a minimally invasive fixation alternative to ...
... Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), ... implant therapy to treat diabetes, today announced that it ... through a placement of shares to Otsuka Pharmaceutical Factory, ... Otsuka group of companies. For the placement, Otsuka will ...
Cached Medicine Technology:Lanx®, Inc. Announces Launch of Concero™ Facet Screw System for Spinal Fusion 2LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 2LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 3LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 4LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 5
The Excel Series from DGH-KOI is an excellent choice for the ophthalmic surgeon performing cataract and other general ophthalmic procedures. With a broad range of blade options and our special Excel ...
New! Visually superior, micrometer handle, single foot plate, blade extends to 3.0 mm....
The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology....
... ClosureWire Vascular Closure System (VCS) utilizes ... Compression., ,The Boomerang ClosureWire technique creates ... of the arteriotomy and just outside ... targeted internal compression of both the ...
Medicine Products: